The research, development, and commercialization of software, algorithms, and artificial intelligence solutions focused on oncology and cancer-related applications, including the analysis and interpretation of biomedical data such as medical images, as well as molecular, genomic, proteomic biomarkers and other relevant data in the field of cancer. The company develops and operates cloud-based platforms and tools to support clinical decision-making and research in the fields of pathology, oncology, and cancer research. The company may provide related services to healthcare providers, laboratories, and research institutions, and acquire, manage, license, and exploit intellectual property rights related to its purpose. The company may create branches and subsidiaries, participate in other enterprises in Switzerland and abroad, and carry out all commercial, financial, or other activities directly or indirectly related to its purpose.